Form 4 for CNMD CONMED Corp
Accepted 2021-09-17 00:00:00 ET · period of report 2021-09-15 · accession 0001127602-21-025509 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-17 | 2021-09-15 | CNMD | Hartman Curt R | Pres, CEO, COB, Dir | S - Sale+OE | $127.39 | -2,500 | 65.0K | -4% | -$318.5K |
| DM | 2021-09-17 | 2021-09-15 | CNMD | Hartman Curt R | Pres, CEO, COB, Dir | M - OptEx | $41.07 | +81.5K | 127.1K | +179% | +$3.35M |
| DM | 2021-09-17 | 2021-09-15 | CNMD | Hartman Curt R | Pres, CEO, COB, Dir | F - Tax | $127.26 | -47.5K | 98.9K | -32% | -$6.05M |
| D | 2021-09-17 | 2021-09-17 | CNMD | Hartman Curt R | Pres, CEO, COB, Dir | G - Gift | $0.00 | -89.0K | 9,949 | -90% | $0 |
| DI | 2021-09-17 | 2021-09-17 | CNMD | Hartman Curt R | Pres, CEO, COB, Dir | G - Gift | $0.00 | +89.0K | 89.0K | New | $0 |
| DM | 2021-09-17 | 2021-09-15 | CNMD | Hartman Curt R | Pres, CEO, COB, Dir | M - OptEx | $0.00 | -81.5K | 111.7K | -42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-15 | S | D | 2,500 | $127.39 | 64,980 | D Trust | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.31 to $127.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 2 | Common | Common Stock | 2021-09-15 | M | A | 34,000 | $39.87 | 98,980 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-15 | F | D | 19,349 | $127.24 | 79,631 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-15 | M | A | 47,500 | $41.93 | 127,131 | D | — | — | |
| 5 | Common | Common Stock | 2021-09-15 | F | D | 28,182 | $127.28 | 98,949 | D | — | — | |
| 6 | Common | Common Stock | 2021-09-17 | G | D | 89,000 | $0.00 | 9,949 | D | — | — | |
| 7 | Common | Common Stock | 2021-09-17 | G | A | 89,000 | $0.00 | 89,000 | I | — | — | |
| 8 | Derivative | Options To Purchase Common Stock | 2021-09-15 | M | D | 34,000 | $0.00 | 0 | D | $39.87 · — to 2026-03-01 | 34,000 Common Stock | (F3) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| 9 | Derivative | Options To Purchase Common Stock | 2021-09-15 | M | D | 47,500 | $0.00 | 111,650 | D | $41.93 · — to 2027-03-01 | 47,500 Common Stock | (F3) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |